Searched for
REMEDESIVIR
Syngene's CEO Jonathan Hunt says India now offers intellectual arbitrage to firms“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...- Health Ministry issues guidelines for rational use of medicines, tests for COVID-19 patientsThe nine-page guidelines have not mentioned the use of these medicines which have been used widely by doctors to treat Covid-19 patients.
- MP COVID-19 crisis administration's criminal negligence: Kamal NathThe former Union minister claimed that hospitals in the state have no beds, injections, oxygen, medicines and ambulances.
- Appalled by Vardhan's statement that there is no shortage of oxygen, vaccines: Chidambaram"I am also appalled by the statement of the UP Chief Minister that there is no shortage of vaccines in UP," he said on Twitter. He asked wh...
- Future generations won't forgive you, Priyanka Gandhi writes to Adityanath on COVID-19 crisisUttar Pradesh Monday reported 249 coronavirus deaths, the highest single-day fatality count so far, and 33,574 fresh cases. The infection h...
- Amid high demand for Remdesivir, 3 lakh vials to be produced daily within two weeks: Mansukh MandaviyaUnion Chemical and Fertilizer Minister Mansukh Mandaviya told ANI that within two weeks, 3 lakh vials of Remdesivir will be supplied to the...
- Facing crunch, Bengaluru hospitals decide to give Remdesivir only to priority groupsAccording to the Private Hospitals and Nursing Homes Association (PHANA), city hospitals are facing a supply gap of up to 80%. “A small qua...
- Remdesivir no life-saving drug in COVID-19: Maharashtra task force"It only arrests the replication of the virus and therefore reduces the hospital stay and convalescence of the patient by one-two days. Thi...
- WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivirThe WHO draft document, seen by Reuters and dated Oct. 30, says the priorities are to secure monoclonal antibodies in a tight market and to...
- Cipla and Hetero seek clinical trial waiver for RemdesivirWhile all new drugs must undergo trials before getting marketing approval in India, the regulator can grant exemptions in public interest a...
- Post Covid, innovative and agile pharma cos will become stronger: GV PrasadWe have been running our factory from day one, says the Co-Chairman and MD of Dr Reddy's.
- Strike when it’s hot! 58% stocks from this sector defy crisis to double pricesThis outperformance came after an underperformance of four years.
Load More
